Future Outlook And Stock Price Performance For InMed Pharmaceuticals Inc (NASDAQ: INM)

NOVA

In today’s recent session, 23.16 million shares of the InMed Pharmaceuticals Inc (NASDAQ:INM) have been traded, and its beta is 0.66. Most recently the company’s share price was $5.98, and it changed around $1.03 or 20.81% from the last close, which brings the market valuation of the company to $4.32M. INM at last check was trading at a discount to its 52-week high of $15.70, offering almost -162.54% off that amount. The share price’s 52-week low was $2.41, which indicates that the recent value has risen by an impressive 59.7% since then. We note from InMed Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 34250.0 shares, with the 3-month average coming to 43.41K.

InMed Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended INM as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

InMed Pharmaceuticals Inc (NASDAQ:INM) trade information

Instantly INM has been showing a green trend so far today with a performance of 20.81% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 8.27 on recent trading dayincreased the stock’s daily price by 27.69%. The company’s shares are currently up 26.16% year-to-date, but still up 41.71% over the last five days. On the other hand, InMed Pharmaceuticals Inc (NASDAQ:INM) is 15.22% up in the 30-day period. We can see from the shorts that 5776.0 shares have been sold at a short interest cover period of 0.12 day(s).

InMed Pharmaceuticals Inc (INM) estimates and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 53.87%.

INM Dividends

InMed Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in February.

InMed Pharmaceuticals Inc (NASDAQ:INM)’s Major holders

VIRTU FINANCIAL LLC, with 0.9017% or 86684.0 shares worth $23000.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.

The former held 41.66 shares worth $0.23 million, making up 5.75% of all outstanding shares.